Juan Carlos Jaen, Ph.D., is a distinguished figure in the biotechnology industry, currently serving as the President of ARCUS BIOSCIENCES INC. Dr. Jaen has a robust background in pharmaceutical research and development, having earned his Ph.D. in Organic Chemistry from the University of California, Berkeley. His career spans over three decades, during which he has held numerous leadership positions at various biotech firms, including roles at Roche, where he was instrumental in advancing drug discovery programs. Throughout his career, Dr. Jaen has been recognized for his contributions to the field of oncology and immunology. He has co-authored numerous scientific publications and holds several patents related to novel therapeutic agents. Before joining ARCUS BIOSCIENCES INC, he served as the Chief Executive Officer of Lpath, Inc., where he led the company's efforts in developing lipid-targeted therapeutics. His strategic vision and scientific expertise have been pivotal in driving the growth and success of the companies he has been involved with. At ARCUS BIOSCIENCES INC, Dr. Jaen plays a critical role in steering the company's mission to develop groundbreaking cancer immunotherapies. As President, he oversees the company's research and development efforts, working closely with a team of dedicated scientists and researchers to bring innovative treatments to patients. His leadership is characterized by a commitment to scientific excellence and a focus on translating cutting-edge research into tangible medical solutions, making him an invaluable asset to ARCUS BIOSCIENCES INC.